Published :
Tables : 110
Figures : 60
Category : Healthcare
No. of Pages : 180
Report Code : HC-1188
Gene Expression Analysis Market Introduction: Gene expression analysis market is forecasted to value over USD 7.6 billion by 2027 end and register a CAGR of over 8.4% by 2027 end. The increasing prevalence, decreasing cost of sequencing and the rising application areas of genomics are fueling the growth of market. In addition, the increasing focus on advanced healthcare system alongside growing preference towards advanced technology in drug development and modern diagnostics is driving the market. Implementation of an initiative like the Precision Medicine Initiative (PMI) has boosted the market growth. The gene expression analysis market is bifurcated into by process, by product, by capacity, by technique, by application, and by region. In terms of process, PCR analysis is expected to hold a major share of the market owing to the frequent upgradations deployed in qPCR and high adoption of these systems. Moreover, the integration of these systems with other steps is positively influencing the market. PCR analysis is prominently preferred by biologists to study the expressions of multiple microorganisms. Based on product, kits & reagents are expected to dominate the market owing to its low price and enhanced efficiency. Due to its low price, there has been a high usage of these products. The introduction of novel kits and reagents has increased sales thus propelling the market. Furthermore, increasing demand for better visualization and data interpretation is resulting in prominent players enhancing bioinformatics tools, thus expanding the gene expression analysis market size. In terms of capacity, low to mid plex is expected to show notable growth. Advancements in stem cell research and an increase in the number of research projects related to single-cell analysis are the major factors expanding the market. Additionally, the development of multiplexed digital characterization systems is positively influencing the market. Based on the technique, RNA expression is the front runner of the market. The rising demand for DNA microarrays and PCR analysis has resulted in the inflation of the market. Besides, the integration of immunoprecipitation assay with these techniques has also positively influenced the market. The emergence of upcoming next-generation sequencing is expected to propagate the market growth further. In terms of application, drug development is expected to control the growth of the market. Factors such as high cost and time have gathered the interest of prominent pharmaceutical players to invest in it. The commercial launch aspect has played a catalyst role in the growth of the market. North America is forecasted dictate market growth. Development of gene therapy, availability of NGS funding and government initiatives are the key factors bolstering the market in the region. Asia-Pacific region represents a lucrative opportunity for manufacturers owing to increasing domestic manufacturing for sequencing systems and increasing bioresearch centres. Furthermore, a rise in the research & development activities and improving healthcare infrastructure is accelerating the growth of the market in the region. Major players of the market are: Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, QIAGEN N.V, PerkinElmer, BGI, GE Healthcare, Hoffman-La Roche Ltd, Bio-Rad Laboratories, Inc. and Pacific Biosciences of California, Inc. Market Segmentation: By Process Sample Collection Purification cDNA synthesis & conversion PCR Analysis Data analysis & interpretation By Product Kits & Reagents DNA Chips Others By Capacity Low- to Mid- Plex High-Plex By Technique RNA Expression Northern Blotting DNA Microarrays PCR Techniques RNA-Seq Promoter Analysis In vitro Transcription/Nuclear Run-On Assays Gel Shift Assays Chromatin Immunoprecipitation (ChIP) Protein Expression & Posttranslational Modification Analysis Western Blotting 2-D Gel Electrophoresis Immunoassays Mass Spectrometry By Application Drug Discovery & Development Clinical Diagnostics Biotechnology & Microbiology Others By Region: North America Europe Asia Pacific Latin America Rest of the World Competitive Landscape: Biorad acquired RainDance Technologies in 2017. RainDance Technologies is a droplet-based PCR systems manufacturers and has an accurate portfolio Thermo Fisher Scientific acquired Affymetrix. The move bolstered Thermo Fisher Scientific's foothold in genetic analysis and cellular products FutureWise Key Takeaways: Growth Prospects SWOT Analysis Key Trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the gene expression analysis market by process, by product, by capacity, by technique, by application, and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) Evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Gene expression analysis market is forecasted to value over USD 7.6 billion by 2027 end and register a CAGR of over 8.4% by 2027 end.
The increasing prevalence, decreasing cost of sequencing and the rising application areas of genomics are fueling the growth of market. In addition, the increasing focus on advanced healthcare system alongside growing preference towards advanced technology in drug development and modern diagnostics is driving the market. Implementation of an initiative like the Precision Medicine Initiative (PMI) has boosted the market growth.
The gene expression analysis market is bifurcated into by process, by product, by capacity, by technique, by application, and by region. In terms of process, PCR analysis is expected to hold a major share of the market owing to the frequent upgradations deployed in qPCR and high adoption of these systems. Moreover, the integration of these systems with other steps is positively influencing the market. PCR analysis is prominently preferred by biologists to study the expressions of multiple microorganisms.
Based on product, kits & reagents are expected to dominate the market owing to its low price and enhanced efficiency. Due to its low price, there has been a high usage of these products. The introduction of novel kits and reagents has increased sales thus propelling the market. Furthermore, increasing demand for better visualization and data interpretation is resulting in prominent players enhancing bioinformatics tools, thus expanding the gene expression analysis market size.
In terms of capacity, low to mid plex is expected to show notable growth. Advancements in stem cell research and an increase in the number of research projects related to single-cell analysis are the major factors expanding the market. Additionally, the development of multiplexed digital characterization systems is positively influencing the market.
Based on the technique, RNA expression is the front runner of the market. The rising demand for DNA microarrays and PCR analysis has resulted in the inflation of the market. Besides, the integration of immunoprecipitation assay with these techniques has also positively influenced the market. The emergence of upcoming next-generation sequencing is expected to propagate the market growth further.
In terms of application, drug development is expected to control the growth of the market. Factors such as high cost and time have gathered the interest of prominent pharmaceutical players to invest in it. The commercial launch aspect has played a catalyst role in the growth of the market.
North America is forecasted dictate market growth. Development of gene therapy, availability of NGS funding and government initiatives are the key factors bolstering the market in the region. Asia-Pacific region represents a lucrative opportunity for manufacturers owing to increasing domestic manufacturing for sequencing systems and increasing bioresearch centres. Furthermore, a rise in the research & development activities and improving healthcare infrastructure is accelerating the growth of the market in the region.
Major players of the market are: Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, QIAGEN N.V, PerkinElmer, BGI, GE Healthcare, Hoffman-La Roche Ltd, Bio-Rad Laboratories, Inc. and Pacific Biosciences of California, Inc.
Market Segmentation:
By Process
By Product
By Capacity
By Technique
By Application
By Region:
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Gene Expression Analysis Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Gene Expression Analysis Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Gene Expression Analysis Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Gene Expression Analysis Market, By Process Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Sample Collection 7.2. Purification 7.3. cDNA synthesis & conversion 7.4. PCR Analysis 7.5. Data analysis & interpretation 8. Global Gene Expression Analysis Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Kits & Reagents 8.2. DNA Chips 8.3. Others 9. Global Gene Expression Analysis Market, By Capacity Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Low- to Mid- Plex 9.2. High-Plex 10. Global Gene Expression Analysis Market, By Technique Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. RNA Expression 10.1.1. Northern Blotting 10.1.2. DNA Microarrays 10.1.3. PCR Techniques 10.1.4. RNA-Seq 10.2. Promoter Analysis 10.2.1. In vitro Transcription/Nuclear Run-On Assays 10.2.2. Gel Shift Assays 10.2.3. Chromatin Immunoprecipitation (ChIP) 10.3. Protein Expression & Posttranslational Modification Analysis 10.3.1. Western Blotting 10.3.2. 2-D Gel Electrophoresis 10.3.3. Immunoassays 10.3.4. Mass Spectrometry 11. Global Gene Expression Analysis Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Drug Discovery & Development 11.2. Clinical Diagnostics 11.3. Biotechnology & Microbiology 11.4. Others 12. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027 13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2020-2027 14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Switzerland 14.2.9. Rest of Western Europe 15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. Singapore 15.2.4. India 15.2.5. Australia and New Zealand 15.2.6. ASEAN 15.2.7. South Korea 15.2.8. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 17.1. Thermo Fisher Scientific 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Illumina, Inc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Agilent Technologies 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. QIAGEN N.V 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. PerkinElmer 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. BGI 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. GE Healthcare 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Hoffman-La Roche Ltd 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Bio-Rad Laboratories, Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. Pacific Biosciences of California, Inc. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 18. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics